
LifeMD (LFMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
LifeMD (LFMD) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $205.5M - $212.5M para el período.
En comparación con la previsión anterior, LifeMD reducido redujo su previsión de ingresos desde un rango anterior de $220M - $230M.
LifeMD ha emitido 28 actualizaciones de orientación entre el noviembre 10, 2022 y el agosto 5, 2026. During this period, the company raised its outlook 9 times and lowered it 12 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.13 | $0.02 | $0.01 |
| Actual | $-0.16 | $-0.20 | $-0.04 | $-0.07 |
| Surprise | -100.0% | -53.8% | -300.0% | -800.0% |
| Revenue | ||||
| Estimate | $49.1M | $48.8M | $45.1M | $62.2M |
| Actual | $47.3M | $50.2M | $46.9M | $60.2M |
| Surprise | -3.75% | +2.88% | +4.00% | -3.26% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.03 | $0.07 | $-0.04 | $-0.06 |
| Revenue | ||||
| Consensus | $48.8M | $61.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.16 | $-0.08 | -100.0 % |
| Q1 | May 6, 2026 | $-0.20 | $-0.13 | -53.8 % |
| Q4 | Mar 9, 2026 | $-0.04 | $0.02 | -300.0 % |
| Q3 | Nov 17, 2025 | $-0.07 | $0.01 | -800.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $47.30M | $49.14M | -3.75 % |
| Q1 | May 6, 2026 | $50.16M | $48.76M | 2.88 % |
| Q4 | Mar 9, 2026 | $46.87M | $45.06M | 4.00 % |
| Q3 | Nov 17, 2025 | $60.17M | $62.20M | -3.26 % |